Objective: Short neck length, and angulated infrarenal aortic necks, are historically associated with sac expansion following endovascular abdominal aortic aneurysm repair. Aorfix (Lombard Medical, Inc, Irvine, Calif), a conformable stent graft US Food and Drug Administration approved for highly angulated necks, was investigated in the US Pythagoras Trial. We investigated the incidence of, and factors related to, sac regression and expansion following implantation of the Aorfix device.
The behavior of the residual aneurysm sac following endovascular abdominal aortic aneurysm repair (EVAR) is viewed as a surrogate of treatment success; this may be particularly critical in patients with hostile neck anatomy such as highly angulated necks. Although the latest iterations of endovascular grafts address issues such as short neck length or poor access vessels, high proximal aortic neck angulation remains a significant barrier, especially with regard to postoperative aneurysm remodeling. 1 Sternbergh et al 2 demonstrated the direct relationship between aortic neck angulation and adverse outcomes in EVAR performed with first generation grafts. More recent studies, with contemporary devices, supported this observation. Indeed, high proximal aortic neck angulation is associated with persistent type Ia and II endoleaks, requirement for remedial procedures, need for delayed open conversion, and aneurysm sac diameter increase with late rupture. [3] [4] [5] [6] [7] [8] As a result, the instructions for use (IFU) for most commercially available EVAR devices specify a proximal aortic neck of <60 . 9 In patients with highly angulated aortic necks, surgeons face the difficult decision of the appropriateness of open abdominal aortic aneurysm (AAA) repair in a patient that may have significant medical comorbidities and, therefore, elevated operative risk. 3, 6, [10] [11] [12] Factors that are associated with favorable sac remodeling, and EVAR success, in patients with highly angulated proximal aortic necks have yet to be determined. The Lombard Aorfix (Lombard Medical, Inc, Irvine, Calif) was designed to accommodate highly angulated aortic necks and is U.S. Food and Drug Administrationapproved to treat proximal necks of up to 90
. Its highly conformable structure molds to both proximal and distal landing zones, and a proximal fishmouth design maximizes proximal seal and neck apposition. The ongoing, prospective, Aorfix Pythagoras trial demonstrated graft performance that was comparable in both high ($60 proximal aortic neck) and "normal" (<60 ) neck angulation cohorts. [13] [14] [15] Although these initial results are encouraging, 16 anatomic and patient factors impacting long-term aortic sac remodeling following implantation of this novel graft have not yet been elucidated. We sought to identify factors relating to sac remodeling in both high and normal angle aortic necks, post-EVAR with the Aorfix device. As sac expansion (>5 mm per Society of Vascular Surgery guidelines) is device-dependent and related to endoleaks and requirements for remedial endovascular or open procedures, identification of factors that impact sac behavior is of interest to vascular surgeons. 17 
METHODS
Pythagoras (ClinicalTrials.gov Identifier NCT00522535) is a prospective trial evaluating the use the Lombard Aorfix bifurcated AAA stent graft (http://usa.lombardmedical. com/index.php) device in high angle proximal aortic necks. The study protocol and informed consent were approved by the Institutional Review Boards at each participating institution. Participants were offered informed consent prior to participation in the study. The trial enrolled patients from 2006 to 2011, and 5-year follow-up data collection is ongoing. The primary outcome measure in the parent study was all-cause mortality rate in the Aorfix group compared with all-cause mortality in an open AAA comparator group. Secondary outcome measures in the parent study include rates of early serious adverse events within 30 days of implantation. Inclusion criteria were AAAs $4.5 cm in diameter, AAAs $4.0 cm in diameter and diagnosed as symptomatic, and a $5 mm increase in diameter of a previously diagnosed AAA within a documented 6-month period. Clinical exclusion criteria were life expectancy of less than 2 years, ruptured aneurysms, mycotic or inflammatory aneurysms, aneurysms that extend proximal to renal artery ostia, any aortic dissection, renal failure (serum creatinine $2.5), recent myocardial infarction or unstable angina, or end-stage chronic obstructive pulmonary disease. Anatomic exclusion factors specific to the trial were (1) proximal aneurysm neck less than 15 mm from the lowest renal artery; (2) superior mesenteric artery to top of sac centerline distance less than 20 mm; (3) distal landing zone less than 15 mm; and (4) aortic or iliac landing zone diameter outside of recommended IFU.
Patients underwent arterial phase, thin-cut computed tomography (CT) before enrollment and yearly following device implantation. Anatomic measurements were performed to a protocol by a core laboratory (M2S; West Lebanon, NH). A total of 31 objective measures (aortic neck diameter/length, iliac diameter/length, etc) were determined from each preoperative CT. Four variables required subjective evaluation (proximal neck thrombus, proximal neck calcium, right/left iliac artery plaque, tortuosity); this data was recorded on an ordinal scale (0 ¼ none; 1 ¼ mild, 2 ¼ moderate, 3 ¼ severe). On postoperative CT imaging, variables determined from the core laboratory included endoleak presence and volume, diameter of the aneurysm sac, proximal and distal seal zone characteristics including angulation, and subjective evaluation of limb patency.
The Lombard Aorfix device was implanted within the recommendations of the IFU (http://www.lombard medical.com/files/aorfix_ifu_-_usa_only.pdf) after patients provided written informed consent. Adjunctive procedures were used at the discretion of the operating surgeon. A host of demographic and clinical data were collected prospectively, as were data relating to operative conduct. Thirty-day outcomes (mortality, major adverse events, need for reintervention, endoleak) as well as yearly clinical outcomes and CT follow-ups were recorded. The number and type of remedial procedures necessary for endoleak and migration were recorded in a database. For data analysis, we defined sac regression or expansion as a change in diameter of $5 mm in diameter on follow-up CT compared with the last preoperative CT scan. The $5-mm cut-off for regression or expansion was chosen in conjunction with established Society of Vascular Surgery guidelines, initially published in 1997 and revised in 2002. 18, 19 Proximal aortic neck angle 20 was defined as the maximum of the following two measurements: (1) the angle (a) between the flow axis of the suprarenal aorta and the infrarenal neck ( Fig 1) ; and (2) the angle (b) between the flow axis of the infrarenal neck and the body of the aneurysm (Fig 1) . Continuous variables were analyzed using the Student t-test or analysis of variance, as appropriate, and categorical data were analyzed using Fisher exact or c 2 tests.
Multivariable analysis was performed using logistic regression models with stepwise elimination using inclusion threshold of P ¼ .20. An a value of .05, corresponding to P value equal to .05 and 95% confidence intervals were used as the criteria for statistical significance. Statistical analysis was performed using SAS v 9.4 software (SAS Institute Inc, Cary, NC).
RESULTS
Aorfix deployment was initiated in 218 patients. At the time of database lock (218 patients were enrolled over 5.5 years), follow-up CT imaging was available at 1-year (n ¼ 165), 2-year (n ¼ 142), 3-year (n ¼ 106), and 4 year (n ¼ 70) time points following graft implantation. On the immediate preoperative "index" CT, proximal neck angle was $60 in 151 patients; the proximal neck in the remaining 67 patients was <60 . Mean age was 75.6 years. Patients tended to be male (71.1%) smokers (73.4%) with a history of hypertension (84.8%) and coronary artery disease (53.6%). Baseline demographics are described in Table I . With regard to baseline aneurysm characteristics, the average proximal neck angle in the study cohort was 71.4 (Table II) . Average neck length was 22.3 mm, and average neck diameter was 22.5 mm. Average iliac artery diameter was 19.4 mm, and average iliac artery length was 59.8 mm. Average maximum aneurysm diameter was 57.5 mm. Subjective evaluation of aortic neck thrombus, aortic calcification, aortic tortuosity, and iliac calcification are described in Table II . In terms of overall sac behavior, sac size decreased or remained stable (<5 mm increase in size) in 98.8% of patients at 1-year postoperatively, 95.1% at 2 years postoperatively, 94.3% at 3 years postoperatively, and 92.9% at 4 years postoperatively (Fig 2) . There was no difference in sac behavior when stratified by proximal neck angle (P > .20 at all time points). The number of patients with sac expansion at the 1-, 2-, 3-, and 4-year time points was two (0 <60 , 2 >60 ), seven (2 <60 5 >60 ), six (2 <60 , 4 >60 ), and five (2 <60 , 3 > 60 ). In the study cohort as a whole, the reintervention rates at 1-year postoperatively was 7.9%; the reintervention rate at 2-years postoperatively was 9.2%. On univariate analysis of demographic, past history, medication, and anatomic/procedural factors related to sac expansion at 1 year postoperatively, only intraoperative endoleak recognition predicted sac expansion (P ¼ .01). Male sex (P ¼ .05), diabetes (P ¼ .01), aortic neck diameter (P ¼ .014), iliac artery diameter (P ¼ .04), and absence of endoleak at the time of the initial procedure (P # .001) were associated with sac regression at 1 year postoperatively on univariate analysis. On multivariable analysis, however, only sex (P ¼ .016) and diabetes (P < .001) were associated with sac regression at 1 year postoperatively. On univariate analysis of demographic, past history, medication, and anatomic/procedural factors related to sac expansion at 4 years postoperatively, hypertension (P ¼ .02), aortic neck thrombus (P ¼ .03), aneurysm tortuosity (P ¼ .01), and the need for reintervention (P ¼ .04) based on postoperative CT were associated with sac expansion. On multivariable analysis, only hypertension (P ¼ .005), aortic tortuosity (P ¼ .05), and need for reintervention (P ¼ .04) based on postoperative CT were associated with expansion. Thirty-four other demographic, past medical history, and procedural factors were not related to sac expansion (Table III) . On univariate analysis of factors related to sac regression at 4 years postoperatively, age (P ¼ .05), mild aortic calcification (vs severe, P ¼ .02), and lack of endoleak detection (P ¼ .004) were associated with sac regression.
On multivariable analysis, age (P ¼ .04) and mild aortic calcification (vs severe, P ¼ .02) were associated with regression. Antiplatelet use (P ¼ .22), anticoagulation status (P ¼ .53), American Society of Anesthesiologists class (P ¼ .57), aortic length neck (P ¼ .18), aortic neck diameter (P ¼ .17), maximum aneurysm diameter (P ¼ .54), iliac artery diameter (P ¼ .13), iliac artery length (P ¼ .08), and proximal neck angle (P ¼ .59) were not associated with sac regression at the 4-year time point (Table IV) .
DISCUSSION
The enthusiasm for endovascular management of infrarenal AAAs has been met with marginal or even poor results in patients with highly angulated proximal aortic necks. In turn, this has ramifications for aneurysm remodeling post EVAR. The link between aneurysm sac behavior (regression and expansion) and efficacy of endovascular repair has been firmly established. Aneurysm growth following EVAR is associated with incomplete aortic exclusion, continued pressurization of the sac, and inherent rupture risk. According to Society of Vascular Surgery guidelines for post-EVAR reporting, the threshold for aneurysm regression or expansion is a change in maximal aneurysm diameter >5 mm. Continued sac enlargement post-EVAR is associated with endoleak, need for intervention, and late rupture. [26] [27] [28] [29] [30] Conversely, sustained sac regression $5 mm is associated with low incidence of type I and II endoleaks, and full aneurysm exclusion. 31, 32 Although in this study CT was the methodology of choice, many clinicians use ultrasound scan for post-EVAR surveillance with the same 5-mm cut-off to define regression or expansion. 33 The most compelling observation from this trial is 93% rate of sac regression or stability at 4 years postoperatively. This data suggests that, potentially in highly angulated necks, the device performs adequately as determined by sac expansion/regression criteria. This compares reasonably with contemporary devices. 31 These are likely patients, based on age (mean age 75 years in the high-angle group) and comorbidities, that may not be offered an open aneurysm repair because of the risk of serious cardiopulmonary complications, or even mortality. There was a paucity of factors identified that affect sac behavior, despite a relatively exhaustive examination. This is likely related to the limitations of our multivariable statistical model (with fewer patients reaching further end points) and the overall low incidence of sac expansion and regression. We were unable to definitively identify factors that predict aneurysm sac behavior using the Lombard device.
Although this study has some important implications regarding endovascular management of aneurysms with highly angulated proximal necks, there are also limitations. Accrual of 218 patients took 5½ years, and a relatively small proportion of patients reached longer end points before the database was locked for analysis. Certainly, 5-year follow-up for all patients will allow for more robust statistical conclusions and is in progress. In the Pythagoras trial, mean aortic neck length for the entire cohort was 22.3 mm. As there is a relationship between proximal neck length and endograft overall performance, the relatively long neck length in this study may have "masked" a potential relationship between neck angle and sac behavior. 21, 34, 35 Finally, the average aneurysm size in the standard angle cohort (54.3 mm maximum diameter) did not reach the commonly accepted indication of 55 mm, and this may have implications with regard to applicability to "real world" practice.
CONCLUSIONS
Post-EVAR remodeling following the implantation of the Lombard Aorfix device results in sac shrinkage or stability in over 90% of patients; longer term follow-up with increased number of patients is necessary to further evaluate factors associated with sac expansion and regression. 
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